{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:52:21Z","timestamp":1792525941253,"version":"4.5.0"},"reference-count":229,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"The Israel Science Foundation","doi-asserted-by":"publisher","award":["3260\/23"],"award-info":[{"award-number":["3260\/23"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Mitochondria serve as central hubs for regulating numerous cellular processes that include metabolism, apoptosis, cell cycle progression, proliferation, differentiation, epigenetics, immune signaling, and aging. The voltage-dependent anion channel 1 (VDAC1) functions as a crucial mitochondrial gatekeeper, controlling the flow of ions, such as Ca2+, nucleotides, and metabolites across the outer mitochondrial membrane, and is also integral to mitochondria-mediated apoptosis. VDAC1 functions in regulating ATP production, Ca2+ homeostasis, and apoptosis, which are essential for maintaining mitochondrial function and overall cellular health. Most cancer cells undergo metabolic reprogramming, often referred to as the \u201cWarburg effect\u201d, supplying tumors with energy and precursors for the biosynthesis of nucleic acids, phospholipids, fatty acids, cholesterol, and porphyrins. Given its multifunctional nature and overexpression in many cancers, VDAC1 presents an attractive target for therapeutic intervention. Our research has demonstrated that silencing VDAC1 expression using specific siRNA in various tumor types leads to a metabolic rewiring of the malignant cancer phenotype. This results in a reversal of oncogenic properties that include reduced tumor growth, invasiveness, stemness, epithelial\u2013mesenchymal transition. Additionally, VDAC1 depletion alters the tumor microenvironment by reducing angiogenesis and modifying the expression of extracellular matrix- and structure-related genes, such as collagens and glycoproteins. Furthermore, VDAC1 depletion affects several epigenetic-related enzymes and substrates, including the acetylation-related enzymes SIRT1, SIRT6, and HDAC2, which in turn modify the acetylation and methylation profiles of histone 3 and histone 4. These epigenetic changes can explain the altered expression levels of approximately 4000 genes that are associated with reversing cancer cells oncogenic properties. Given VDAC1\u2019s critical role in regulating metabolic and energy processes, targeting it offers a promising strategy for anti-cancer therapy. We also highlight the role of VDAC1 expression in various disease pathologies, including cardiovascular, neurodegenerative, and viral and bacterial infections, as explored through siRNA targeting VDAC1. Thus, this review underscores the potential of targeting VDAC1 as a strategy for addressing high-energy-demand cancers. By thoroughly understanding VDAC1\u2019s diverse roles in metabolism, energy regulation, mitochondrial functions, and other cellular processes, silencing VDAC1 emerges as a novel and strategic approach to combat cancer.<\/jats:p>","DOI":"10.3390\/biom14101304","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T03:49:34Z","timestamp":1729136974000},"page":"1304","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9881-0076","authenticated-orcid":false,"given":"Tasleem","family":"Arif","sequence":"first","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"},{"name":"Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0833-8407","authenticated-orcid":false,"given":"Anna","family":"Shteinfer-Kuzmine","sequence":"additional","affiliation":[{"name":"National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-4340","authenticated-orcid":false,"given":"Varda","family":"Shoshan-Barmatz","sequence":"additional","affiliation":[{"name":"National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel"},{"name":"Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.bbamem.2014.10.040","article-title":"The mitochondrial voltage-dependent anion channel 1 in tumor cells","volume":"1848","author":"Admoni","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mam.2010.03.002","article-title":"VDAC, a multi-functional mitochondrial protein regulating cell life and death","volume":"31","author":"Zweckstetter","year":"2010","journal-title":"Mol. Aspects Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15698\/cst2017.10.104","article-title":"VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress","volume":"1","author":"Maldonado","year":"2017","journal-title":"Cell Stress"},{"key":"ref_4","first-page":"822","article-title":"The role of the voltage-dependent anion channels in the outer membrane of mitochondria in the regulation of cellular metabolism","volume":"55","author":"Kholmukhamedov","year":"2010","journal-title":"Biofizika"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mito.2011.04.001","article-title":"VDAC, a multi-functional mitochondrial protein as a pharmacological target","volume":"12","year":"2012","journal-title":"Mitochondrion"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Magri, A., Reina, S., and De Pinto, V. (2018). VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis. Front. Chem., 6.","DOI":"10.3389\/fchem.2018.00108"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bbamem.2011.10.019","article-title":"Voltage-dependant anion channels: Novel insights into isoform function through genetic models","volume":"1818","author":"Raghavan","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bbabio.2010.01.031","article-title":"Characterization of human VDAC isoforms: A peculiar function for VDAC3?","volume":"1797","author":"Guarino","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zeth, K., and Zachariae, U. (2018). Ten Years of High Resolution Structural Research on the Voltage Dependent Anion Channel (VDAC)-Recent Developments and Future Directions. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.00108"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.bbamem.2011.10.005","article-title":"VDAC isoforms in mammals","volume":"1818","author":"Messina","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1126\/science.1161302","article-title":"Solution structure of the integral human membrane protein VDAC-1 in detergent micelles","volume":"321","author":"Hiller","year":"2008","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17742","DOI":"10.1073\/pnas.0809634105","article-title":"The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating","volume":"105","author":"Ujwal","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.0808115105","article-title":"Structure of the human voltage-dependent anion channel","volume":"105","author":"Bayrhuber","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.sbi.2009.07.013","article-title":"The role of solution NMR in the structure determinations of VDAC-1 and other membrane proteins","volume":"19","author":"Hiller","year":"2009","journal-title":"Curr. Opin. Struc. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13794","DOI":"10.1074\/jbc.273.22.13794","article-title":"Bacterial expression and characterization of the mitochondrial outer membrane channel. Effects of n-terminal modifications","volume":"273","author":"Koppel","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1023\/A:1022489832594","article-title":"Minireview: On the structure and gating mechanism of the mitochondrial channel, VDAC","volume":"29","author":"Mannella","year":"1997","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13593","DOI":"10.1074\/jbc.271.23.13593","article-title":"The role of the N and C termini of recombinant Neurospora mitochondrial porin in channel formation and voltage-dependent gating","volume":"271","author":"Popp","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20112079","article-title":"Structure-based analysis of VDAC1: N-terminus location, translocation, channel gating and association with anti-apoptotic proteins","volume":"444","author":"Geula","year":"2012","journal-title":"Biochem. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1073\/pnas.0600103103","article-title":"The expression level of the voltage-dependent anion channel controls life and death of the cell","volume":"103","author":"Sivan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbabio.2004.02.009","article-title":"Subcellular localization of VDAC in mitochondria and ER in the cerebellum","volume":"1657","author":"Zalk","year":"2004","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13482","DOI":"10.1074\/jbc.M708216200","article-title":"Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: Mapping the site of binding","volume":"283","author":"Zaid","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Neumann, D., Buckers, J., Kastrup, L., Hell, S.W., and Jakobs, S. (2010). Two-color STED microscopy reveals different degrees of colocalization between hexokinase-I and the three human VDAC isoforms. PMC Biophys., 3.","DOI":"10.1186\/1757-5036-3-4"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/bj20031465","article-title":"In self-defence: Hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death","volume":"377","author":"Israelson","year":"2004","journal-title":"Biochem. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"23152","DOI":"10.1074\/jbc.M112.345918","article-title":"Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein","volume":"287","author":"Arbel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_25","first-page":"74","article-title":"VDAC, the voltage-dependent anion channel: Function, regulation & mitochondrial signaling in cell life and death","volume":"4","author":"Arbel","year":"2008","journal-title":"Cell Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.cdd.4401599","article-title":"The voltage-dependent anion channel-1 modulates apoptotic cell death","volume":"12","author":"Zaid","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Shoshan-Barmatz, V., and Mizrachi, D. (2012). VDAC1: From structure to cancer therapy. Front. Oncol., 2.","DOI":"10.3389\/fonc.2012.00164"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"30670","DOI":"10.1074\/jbc.M115.691493","article-title":"The Voltage-dependent Anion Channel 1 Mediates Amyloid beta Toxicity and Represents a Potential Target for Alzheimer Disease Therapy","volume":"290","author":"Smilansky","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s10354-011-0887-5","article-title":"Apoptogenic interactions of plasmalemmal type-1 VDAC and Abeta peptides via GxxxG motifs induce Alzheimer\u2019s disease\u2014A basic model of apoptosis?","volume":"161","author":"Thinnes","year":"2011","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1242\/jcs.040188","article-title":"The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins","volume":"122","author":"Arbel","year":"2009","journal-title":"J. Cell Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1074\/jbc.M109.082990","article-title":"Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity","volume":"285","author":"Arbel","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/bi061577h","article-title":"NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL","volume":"46","author":"Malia","year":"2007","journal-title":"Biochemistry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1074\/jbc.275.16.12321","article-title":"Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c","volume":"275","author":"Shimizu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/20959","article-title":"Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC","volume":"399","author":"Shimizu","year":"1999","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bpj.2011.12.049","article-title":"The role of lipids in VDAC oligomerization","volume":"102","author":"Betaneli","year":"2012","journal-title":"Biophys. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1128\/MCB.00165-10","article-title":"Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis","volume":"30","author":"Keinan","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/abbs\/gmx106","article-title":"Metformin as an anti-cancer agent: Actions and mechanisms targeting cancer stem cells","volume":"50","author":"Saini","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2174\/092986712798992110","article-title":"Mitochondrial VDAC1: Function in cell life and death and a target for cancer therapy","volume":"19","author":"Golan","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10863-008-9147-9","article-title":"Uncovering the role of VDAC in the regulation of cell life and death","volume":"40","author":"Keinan","year":"2008","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/B978-0-12-386931-9.00011-8","article-title":"Oligomerization of the mitochondrial protein VDAC1: From structure to function and cancer therapy","volume":"117","author":"Mizrachi","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/BJ20041356","article-title":"Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria","volume":"386","author":"Zalk","year":"2005","journal-title":"Biochem. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10863-008-9144-z","article-title":"Approaching the structure of human VDAC1, a key molecule in mitochondrial cross-talk","volume":"40","author":"Zeth","year":"2008","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1074\/jbc.M111.268920","article-title":"Structure-based analysis of VDAC1 protein: Defining oligomer contact sites","volume":"287","author":"Geula","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/bse0470037","article-title":"Mitochondrial metabolite transport","volume":"47","author":"Palmieri","year":"2010","journal-title":"Essays Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/BJ20091690","article-title":"VDAC1 cysteine residues: Topology and function in channel activity and apoptosis","volume":"427","author":"Aram","year":"2010","journal-title":"Biochem. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.bbamem.2011.12.026","article-title":"VDAC structure, selectivity, and dynamics","volume":"1818","author":"Colombini","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2174\/138161206777585111","article-title":"The voltage-dependent anion channel (VDAC): Function in intracellular signalling, cell life and cell death","volume":"12","author":"Israelson","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbamcr.2013.03.017","article-title":"The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis","volume":"1833","author":"Keinan","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.bbamcr.2014.03.021","article-title":"Ca2+-mediated regulation of VDAC1 expression levels is associated with cell death induction","volume":"1843","author":"Weisthal","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"23563","DOI":"10.1074\/jbc.M115.648774","article-title":"A New Fungal Diterpene Induces VDAC1-dependent Apoptosis in Bax\/Bak-deficient Cells","volume":"290","author":"Huang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1074\/jbc.M112.339580","article-title":"Hormone-induced 14-3-3gamma adaptor protein regulates steroidogenic acute regulatory protein activity and steroid biosynthesis in MA-10 Leydig cells","volume":"287","author":"Aghazadeh","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"25655","DOI":"10.1074\/jbc.M111.228692","article-title":"Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex","volume":"286","author":"Lee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.ymthe.2019.06.017","article-title":"A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model","volume":"27","author":"Pittala","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Shoshan-Barmatz, V., Krelin, Y., Shteinfer-Kuzmine, A., and Arif, T. (2017). Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00154"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Shoshan-Barmatz, V., Shteinfer-Kuzmine, A., and Verma, A. (2020). VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases. Biomolecules, 10.","DOI":"10.3390\/biom10111485"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"24986","DOI":"10.1074\/jbc.M116.744284","article-title":"Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction","volume":"291","author":"Shalev","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4161\/chan.3.3.9196","article-title":"Crystal packing analysis of murine VDAC1 crystals in a lipidic environment reveals novel insights on oligomerization and orientation","volume":"3","author":"Ujwal","year":"2009","journal-title":"Channels"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.bbamcr.2016.04.002","article-title":"VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis","volume":"1863","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Hu, H., Guo, L., Overholser, J., and Wang, X. (2022). Mitochondrial VDAC1: A Potential Therapeutic Target of Inflammation-Related Diseases and Clinical Opportunities. Cells, 11.","DOI":"10.3390\/cells11193174"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2016.05.076","article-title":"Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan","volume":"166","author":"Wolf","year":"2016","journal-title":"Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ymthe.2021.06.024","article-title":"The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: A potential therapeutic target","volume":"30","author":"Verma","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.aav4011","article-title":"VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease","volume":"366","author":"Kim","year":"2019","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Rai, N.K., Singh, V., Li, L., Willard, B., Tripathi, A., and Dutta, R. (2021). Comparative Proteomic Profiling Identifies Reciprocal Expression of Mitochondrial Proteins Between White and Gray Matter Lesions From Multiple Sclerosis Brains. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.779003"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cmet.2018.09.008","article-title":"Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in \u03b2 Cells","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40035-022-00329-7","article-title":"Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer\u2019s disease protects against mitochondrial dysfunction and mitigates brain pathology","volume":"11","author":"Verma","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10565-021-09624-x","article-title":"Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury","volume":"38","author":"Niu","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yjmcc.2018.10.015","article-title":"Central role of RIPK1-VDAC1 pathway on cardiac impairment in a non-human primate model of rheumatoid arthritis","volume":"125","author":"Zeng","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Paschon, V., Morena, B.C., Correia, F.F., Beltrame, G.R., dos Santos, G.B., Cristante, A.F., and Kihara, A.H. (2019). VDAC1 is essential for neurite maintenance and the inhibition of its oligomerization protects spinal cord from demyelination and facilitates locomotor function recovery after spinal cord injury. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-50506-4"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"108863","DOI":"10.1016\/j.celrep.2021.108863","article-title":"Metabolic programs define dysfunctional immune responses in severe COVID-19 patients","volume":"34","author":"Thompson","year":"2021","journal-title":"Cell Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","article-title":"The cGAS-STING pathway drives type I IFN immunopathology in COVID-19","volume":"603","author":"Gulen","year":"2022","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: Cancer\u2019s Achilles\u2019 heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mehy.2010.09.008","article-title":"Combination therapy targeting cancer metabolism","volume":"76","author":"Wenger","year":"2011","journal-title":"Med. Hypotheses"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/neuonc\/now297","article-title":"VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties","volume":"19","author":"Arif","year":"2017","journal-title":"Neuro Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1038\/mtna.2014.9","article-title":"Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo","volume":"3","author":"Arif","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Ko, J.H., Gu, W., Lim, I., Zhou, T., and Bang, H. (2014). Expression profiling of mitochondrial voltage-dependent anion channel-1 associated genes predicts recurrence-free survival in human carcinomas. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110094"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Admoni-Elisha, L., Nakdimon, I., Shteinfer, A., Prezma, T., Arif, T., Arbel, N., Melkov, A., Zelichov, O., Levi, I., and Shoshan-Barmatz, V. (2016). Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148500"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3858\/emm.2009.41.2.013","article-title":"Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells","volume":"41","author":"Yoo","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1159\/000438588","article-title":"Mitochondrial Proteomics Approach Reveals Voltage-Dependent Anion Channel 1 (VDAC1) as a Potential Biomarker of Gastric Cancer","volume":"37","author":"Gao","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.18632\/oncotarget.6704","article-title":"Clinical implication of voltage-dependent anion channel 1 in uterine cervical cancer and its action on cervical cancer cells","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/pr800152u","article-title":"Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling","volume":"7","author":"Alfonso","year":"2008","journal-title":"J. Proteome Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4161\/cbt.5.11.3302","article-title":"Furanonaphthoquinones cause apoptosis of cancer cells by inducing the production of reactive oxygen species by the mitochondrial voltage-dependent anion channel","volume":"5","author":"Simamura","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1447-073X.2008.00241.x","article-title":"Bioreductive activation of quinone antitumor drugs by mitochondrial voltage-dependent anion channel 1","volume":"83","author":"Simamura","year":"2008","journal-title":"Anat. Sci. Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1046\/j.1432-1327.2000.01687.x","article-title":"Characterization of porin isoforms expressed in tumor cells","volume":"267","author":"Shinohara","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.7754\/Clin.Lab.2015.150328","article-title":"Novel Molecular Regulators of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis in NSCLC Cells","volume":"61","author":"Ge","year":"2015","journal-title":"Clin. Lab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/pr4002096","article-title":"Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism","volume":"12","author":"Pernemalm","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10863-008-9158-6","article-title":"Mitochondrial voltage-dependent anion channels (VDACs) as novel pharmacological targets for anti-cancer agents","volume":"40","author":"Simamura","year":"2008","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1074\/jbc.M803614200","article-title":"Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity","volume":"284","author":"Arzoine","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00253-007-0984-y","article-title":"Applications of RNA interference: Current state and prospects for siRNA-based strategies in vivo","volume":"76","author":"Aigner","year":"2007","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI33494","article-title":"Nonviral delivery of synthetic siRNAs in vivo","volume":"117","author":"Akhtar","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1385\/CBB:39:3:279","article-title":"The voltage-dependent anion channel: Characterization, modulation, and role in mitochondrial function in cell life and death","volume":"39","author":"Gincel","year":"2003","journal-title":"Cell Biochem. Biophys."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/B:MCBI.0000009862.17396.8d","article-title":"VDAC: The channel at the interface between mitochondria and the cytosol","volume":"256\u2013257","author":"Colombini","year":"2004","journal-title":"Mol. Cell Biochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.omtn.2019.05.003","article-title":"Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells","volume":"17","author":"Arif","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Arif, T., Paul, A., Krelin, Y., Shteinfer-Kuzmine, A., and Shoshan-Barmatz, V. (2018). Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States. Cancers, 10.","DOI":"10.3390\/cancers10120499"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e12288","DOI":"10.14814\/phy2.12288","article-title":"Human alveolar epithelial type II cells in primary culture","volume":"3","author":"Mao","year":"2015","journal-title":"Physiol. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1007\/s00018-008-8224-x","article-title":"Roles of p53, MYC and HIF-1 in regulating glycolysis\u2014The seventh hallmark of cancer","volume":"65","author":"Yeung","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/JTO.0b013e31818020eb","article-title":"The International Epidemiology of Lung Cancer: Geographical distribution and secular trends","volume":"3","author":"Youlden","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.lungcan.2004.07.998","article-title":"Tobacco smoking and cancer: A brief review of recent epidemiological evidence","volume":"45","author":"Sasco","year":"2004","journal-title":"Lung Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(02)00815-X","article-title":"Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention","volume":"3","author":"Hecht","year":"2002","journal-title":"Lancet Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1440-1843.2011.02095.x","article-title":"Pulmonary adenocarcinoma: A renewed entity in 2011","volume":"17","author":"Kadara","year":"2012","journal-title":"Respirology"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Araujo, L.H., Horn, L., Merritt, R.E., Shilo, K., Xu-Welliver, M., and Carbone, D.P. (2020). Cancer of the Lung: Non\u2013Small Cell Lung Cancer and Small Cell Lung Cancer. Abeloff\u2019s Clinical Oncology, Elsevier. [6th ed.].","DOI":"10.1016\/B978-0-323-47674-4.00069-4"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/03009734.2019.1692101","article-title":"The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung","volume":"125","author":"Galindo","year":"2020","journal-title":"Upsala J. Med. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Zerbib, E., Arif, T., Shteinfer-Kuzmine, A., Chalifa-Caspi, V., and Shoshan-Barmatz, V. (2021). VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment. Cancers, 13.","DOI":"10.3390\/cancers13112850"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Melnikov, N., Pittala, S., Shteinfer-Kuzmine, A., and Shoshan-Barmatz, V. (2024). Mitochondrial VDAC1 silencing in urethane-induced lung cancer inhibits tumor growth and alters cancer oncogenic properties. Cancers, 16.","DOI":"10.3390\/cancers16172970"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Wicha","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0140-6736(11)61539-0","article-title":"Gene expression profiling in breast cancer: Classification, prognostication, and prediction","volume":"378","author":"Pusztai","year":"2011","journal-title":"Lancet"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.2407","article-title":"Refinement of breast cancer classification by molecular characterization of histological special types","volume":"216","author":"Weigelt","year":"2008","journal-title":"J. Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: Clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/BCTT.S426121","article-title":"Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer","volume":"15","author":"Tong","year":"2023","journal-title":"Breast Cancer Targets Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"ref_114","unstructured":"Kaseb, H., and Aeddula, N.R. (2021). Bladder Cancer. StatPearls, StatPearls."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.path.2022.07.003","article-title":"Urothelial Carcinoma: Divergent Differentiation and Morphologic Subtypes","volume":"15","author":"Gandhi","year":"2022","journal-title":"Surg. Pathol. Clin."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Alhozeel, B., Pandey, S.K., Shteinfer-Kuzmine, A., Santhanam, M., and Shoshan-Barmatz, V. (2024). Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer. Cells, 13.","DOI":"10.3390\/cells13070627"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Alfaleh, M.A., Howard, C.B., Sedliarou, I., Jones, M.L., Gudhka, R., Vanegas, N., Weiss, J., Suurbach, J.H., de Bakker, C.J., and Milne, M.R. (2017). Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186137"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1539\/joh.16-2002-ST","article-title":"The global health dimensions of asbestos and asbestos-related diseases","volume":"58","author":"Ramazzini","year":"2016","journal-title":"J. Occup. Health"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","article-title":"Malignant Mesothelioma and Its Non-Asbestos Causes","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.21037\/atm.2017.04.29","article-title":"Mesothelioma: Recent highlights","volume":"5","author":"Carbone","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4161\/cbt.9.12.11879","article-title":"Downregulation of voltage-dependent anion channel-1 expression by RNA interference prevents cancer cell growth in vivo","volume":"9","author":"Koren","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Amsalem, Z., Arif, T., Shteinfer-Kuzmine, A., Chalifa-Caspi, V., and Shoshan-Barmatz, V. (2020). The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link. Cancers, 12.","DOI":"10.3390\/cancers12041031"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Pandey, S.K., Machlof-Cohen, R., Santhanam, M., Shteinfer-Kuzmine, A., and Shoshan-Barmatz, V. (2022). Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks. Biomolecules, 12.","DOI":"10.3390\/biom12070895"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2005.12.005","article-title":"The tumor microenvironment in the post-PAGET era","volume":"242","author":"Witz","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1158\/1078-0432.CCR-14-1905","article-title":"Stromal CD8+ T-cell Density-A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer","volume":"21","author":"Donnem","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/08820139.2012.680634","article-title":"Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: Mechanisms of T cell suppression and therapeutic perspectives","volume":"41","author":"Raber","year":"2012","journal-title":"Immunol. Investig."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1073\/pnas.162488599","article-title":"Diversity, topographic differentiation, and positional memory in human fibroblasts","volume":"99","author":"Chang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","article-title":"Drug resistance and Cancer stem cells","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12935-023-02868-z","article-title":"MicroRNA-122 in human cancers: From mechanistic to clinical perspectives","volume":"23","author":"Hashemipour","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Bargaje, R., Gupta, S., Sarkeshik, A., Park, R., Xu, T., Sarkar, M., Halimani, M., Roy, S.S., Yates, J., and Pillai, B. (2012). Identification of novel targets for miR-29a using miRNA proteomics. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043243"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12012-021-09705-7","article-title":"MiR-7a-5p Attenuates Hypoxia\/Reoxygenation-Induced Cardiomyocyte Apoptosis by Targeting VDAC1","volume":"22","author":"Lu","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"34924","DOI":"10.18632\/oncotarget.5318","article-title":"CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"10235","DOI":"10.1007\/s13277-016-4836-1","article-title":"MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.M115.691352","article-title":"MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression","volume":"291","author":"Chaudhuri","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.122.001234","article-title":"RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies","volume":"384","author":"Traber","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.copbio.2014.11.012","article-title":"Metabolism and epigenetics: A link cancer cells exploit","volume":"34","author":"Carrer","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/erm.09.53","article-title":"DNA methylation and cancer diagnosis: New methods and applications","volume":"9","author":"Dehan","year":"2009","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","article-title":"Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes","volume":"62","author":"Etchegaray","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biocel.2008.09.011","article-title":"Epigenetics and human disease","volume":"41","author":"Hirst","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","article-title":"Influence of metabolism on epigenetics and disease","volume":"153","author":"Kaelin","year":"2013","journal-title":"Cell"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.tibs.2012.07.008","article-title":"Gatekeepers of chromatin: Small metabolites elicit big changes in gene expression","volume":"37","author":"Kaochar","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2012.06.001","article-title":"Metabolic regulation of epigenetics","volume":"16","author":"Lu","year":"2012","journal-title":"Cell Metab."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1476-5381.2012.02002.x","article-title":"Epigenetic mechanisms in anti-cancer actions of bioactive food components\u2014The implications in cancer prevention","volume":"167","author":"Stefanska","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: A cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2119\/molmed.2016.00051","article-title":"Compartmentation of metabolites in regulating epigenome of cancer","volume":"22","author":"Zhao","year":"2016","journal-title":"Mol. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1083\/jcb.201803061","article-title":"Metabolic regulation of chromatin modifications and gene expression","volume":"217","author":"Schvartzman","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1124\/jpet.112.192153","article-title":"Warburg revisited: Regulation of mitochondrial metabolism by voltage-dependent anion channels in cancer cells","volume":"342","author":"Maldonado","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of site-specific histone acetylation and deacetylation","volume":"76","author":"Shahbazian","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/CCO.0b013e32834d813b","article-title":"SIRT1, metabolism and cancer","volume":"24","author":"Knight","year":"2012","journal-title":"Curr. Opin. Oncol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.neo.2018.02.012","article-title":"Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide","volume":"20","author":"Pittala","year":"2018","journal-title":"Neoplasia"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1093\/hmg\/dds360","article-title":"Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-2010-100966","article-title":"Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer\u2019s disease transgenic mice: An insight into the pathogenic effects of amyloid-beta","volume":"23","author":"Vilarino","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00401-008-0370-6","article-title":"Dystrophic neurites of senile plaques in Alzheimer\u2019s disease are deficient in cytochrome c oxidase","volume":"116","author":"Ferrer","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4161\/isl.2.5.12639","article-title":"Mitochondrial proteome analysis reveals altered expression of voltage dependent anion channels in pancreatic beta-cells exposed to high glucose","volume":"2","author":"Ahmed","year":"2010","journal-title":"Islets"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"C1055","DOI":"10.1152\/ajpcell.00087.2012","article-title":"VDAC: Old protein with new roles in diabetes","volume":"303","author":"Sasaki","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12012-011-9111-5","article-title":"Isoproterenol Cytotoxicity is Dependent on the Differentiation State of the Cardiomyoblast H9c2 Cell Line","volume":"11","author":"Branco","year":"2011","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2017.12.015","article-title":"WDR26\/MIP2 interacts with VDAC1 and regulates VDAC1 expression levels in H9c2 cells","volume":"117","author":"Jiang","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"22101","DOI":"10.1038\/s41598-020-79056-w","article-title":"VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism","volume":"10","author":"Verma","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mnfr.201400730","article-title":"Long-term oral resveratrol intake provides nutritional preconditioning against myocardial ischemia\/reperfusion injury: Involvement of VDAC1 downregulation","volume":"59","author":"Liao","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0735-1097(01)01509-1","article-title":"Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: Insight into the pathogenesis of phenotypes","volume":"38","author":"Lim","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1002\/pmic.200700734","article-title":"Myocardial ischemia\/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor","volume":"7","author":"Schwertz","year":"2007","journal-title":"Proteomics"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2018.11.016","article-title":"Resveratrol protects cardiomyocytes against anoxia\/reoxygenation via dephosphorylation of VDAC1 by Akt-GSK3 beta pathway","volume":"843","author":"Tian","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.biopha.2017.08.046","article-title":"VDAC1 deacetylation is involved in the protective effects of resveratrol against mitochondria-mediated apoptosis in cardiomyocytes subjected to anoxia\/reoxygenation injury","volume":"95","author":"Tong","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.mito.2018.10.002","article-title":"Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and association with hexokinase II in mitochondria","volume":"46","author":"Yang","year":"2019","journal-title":"Mitochondrion"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Zamarin, D., Garcia-Sastre, A., Xiao, X., Wang, R., and Palese, P. (2005). Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog., 1.","DOI":"10.1371\/journal.ppat.0010004"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/JVI.74.6.2840-2846.2000","article-title":"Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential","volume":"74","author":"Rahmani","year":"2000","journal-title":"J. Virol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mito.2004.06.012","article-title":"Mitochondrial membrane permeabilization by HIV-1 Vpr","volume":"4","author":"Deniaud","year":"2004","journal-title":"Mitochondrion"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"21124","DOI":"10.1074\/jbc.M701696200","article-title":"The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death","volume":"282","author":"Moin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.febslet.2006.12.057","article-title":"Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC","volume":"581","author":"Qiao","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Jitobaom, K., Tongluan, N., and Smith, D.R. (2016). Involvement of voltage-dependent anion channel (VDAC) in dengue infection. Sci. Rep., 6.","DOI":"10.1038\/srep35753"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1074\/jbc.M114.585687","article-title":"The association of receptor of activated protein kinase C 1(RACK1) with infectious bursal disease virus viral protein VP5 and voltage-dependent anion channel 2 (VDAC2) inhibits apoptosis and enhances viral replication","volume":"290","author":"Lin","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1128\/JVI.06104-11","article-title":"Critical role for voltage-dependent anion channel 2 in infectious bursal disease virus-induced apoptosis in host cells via interaction with VP5","volume":"86","author":"Li","year":"2012","journal-title":"J. Virol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Han, C., Zeng, X., Yao, S., Gao, L., Zhang, L., Qi, X., Duan, Y., Yang, B., Gao, Y., and Liu, C. (2017). Voltage-Dependent Anion Channel 1 Interacts with Ribonucleoprotein Complexes to Enhance Infectious Bursal Disease Virus Polymerase Activity. J. Virol., 91.","DOI":"10.1128\/JVI.00584-17"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1002\/pmic.200900285","article-title":"Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats","volume":"9","author":"Gong","year":"2009","journal-title":"Proteomics"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bbabio.2016.04.005","article-title":"Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation","volume":"1857","author":"Arif","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1038\/cddis.2013.114","article-title":"Role of alpha-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction","volume":"4","author":"Mitra","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000492875","article-title":"Targeting Peroxisome Proliferator Activated Receptor alpha (PPAR alpha) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes","volume":"49","author":"Kar","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Li, X., Wang, H., Yao, B., Xu, W., Chen, J., and Zhou, X. (2016). lncRNA H19\/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy. Sci. Rep., 6.","DOI":"10.1038\/srep36340"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer\u2019s disease brain is associated with mitochondrial dysfunction","volume":"26","author":"Devi","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/NMM:5:2:147","article-title":"Differential expression of oxidative phosphorylation genes in patients with Alzheimer\u2019s disease: Implications for early mitochondrial dysfunction and oxidative damage","volume":"5","author":"Manczak","year":"2004","journal-title":"Neuromolecular Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: Implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer\u2019s disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.40.8.1302","article-title":"Cytochrome oxidase deficiency in Alzheimer\u2019s disease","volume":"40","author":"Parker","year":"1990","journal-title":"Neurology"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients","volume":"21","author":"Maurer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddh140","article-title":"Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer\u2019s disease","volume":"13","author":"Reddy","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer\u2019s disease neurons: Implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","article-title":"Mitochondrial Abeta: A potential focal point for neuronal metabolic dysfunction in Alzheimer\u2019s disease","volume":"19","author":"Caspersen","year":"2005","journal-title":"FASEB J."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2011.09.001","article-title":"Mitochondrial dysfunction and accumulation of the beta-secretase-cleaved C-terminal fragment of APP in Alzheimer\u2019s disease transgenic mice","volume":"45","author":"Devi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer\u2019s disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00109-008-0391-6","article-title":"Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice","volume":"86","author":"Eckert","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","article-title":"Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer\u2019s disease","volume":"20","author":"Calkins","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease","volume":"29","author":"Wang","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.3233\/JAD-2010-100564","article-title":"Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer\u2019s disease neurons","volume":"20","author":"Manczak","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbadis.2011.01.007","article-title":"Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer\u2019s disease neurons","volume":"1812","author":"Calkins","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000283484","article-title":"Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons","volume":"7","author":"Wang","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"ref_203","first-page":"51","article-title":"Mitochondria morphology and DNA content upon sublethal exposure to beta-amyloid(1-42) peptide","volume":"32","author":"Diana","year":"2008","journal-title":"Coll. Antropol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/09687860601055559","article-title":"Voltage-dependent anion channel (VDAC) participates in amyloid beta-induced toxicity and interacts with plasma membrane estrogen receptor alpha in septal and hippocampal neurons","volume":"24","author":"Marin","year":"2007","journal-title":"Mol. Membr. Biol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","article-title":"VDAC1, mitochondrial dysfunction, and Alzheimer\u2019s disease","volume":"131","author":"Gupta","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.bbadis.2013.09.008","article-title":"RNA silencing of genes involved in Alzheimer\u2019s disease enhances mitochondrial function and synaptic activity","volume":"1832","author":"Manczak","year":"2013","journal-title":"Bba-Mol. Basis Dis."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s12035-018-1164-z","article-title":"Vdac1 Downregulation Causes Mitochondrial Disintegration Leading to Hippocampal Neurodegeneration in Scopolamine-Induced Amnesic Mice","volume":"56","author":"Baghel","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2174\/1570159X19666210402104054","article-title":"siRNA Therapeutics: Future Promise for Neurodegenerative Diseases","volume":"19","author":"Amiri","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"114968","DOI":"10.1016\/j.addr.2023.114968","article-title":"siRNA drug delivery across the blood-brain barrier in Alzheimer\u2019s disease","volume":"199","author":"Anis","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Angajala, A., Lim, S., Phillips, J.B., Kim, J.H., Yates, C., You, Z., and Tan, M. (2018). Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01605"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Breda, C.N.S., Davanzo, G.G., Basso, P.J., Saraiva Camara, N.O., and Moraes-Vieira, P.M.M. (2019). Mitochondria as central hub of the immune system. Redox Biol., 26.","DOI":"10.1016\/j.redox.2019.101255"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev.micro.53.1.577","article-title":"Viruses and apoptosis","volume":"53","author":"Roulston","year":"1999","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ni1102-1013","article-title":"To kill or be killed: Viral evasion of apoptosis","volume":"3","author":"Benedict","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Danelishvili, L., Chinison, J.J.J., Pham, T., Gupta, R., and Bermudez, L.E. (2017). The Voltage-Dependent Anion Channels (VDAC) of Mycobacterium avium phagosome are associated with bacterial survival and lipid export in macrophages. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-06700-3"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s10495-014-1045-5","article-title":"Inhibition of VDAC1 prevents Ca2+-mediated oxidative stress and apoptosis induced by 5-aminolevulinic acid mediated sonodynamic therapy in THP-1 macrophages","volume":"19","author":"Chen","year":"2014","journal-title":"Apoptosis"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/nprot.2012.131","article-title":"Exosome-mediated delivery of siRNA in vitro and in vivo","volume":"7","author":"Lee","year":"2012","journal-title":"Nat. Protoc."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.addr.2016.06.011","article-title":"Recent progress in development of siRNA delivery vehicles for cancer therapy","volume":"104","author":"Kim","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"107518","DOI":"10.1016\/j.cclet.2022.05.032","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","volume":"34","author":"Liu","year":"2023","journal-title":"Chinese Chem. Lett."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.drudis.2022.01.003","article-title":"Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases","volume":"27","author":"Mishra","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Massaro, C., Sgueglia, G., Frattolillo, V., Baglio, S.R., Altucci, L., and Dell\u2019Aversana, C. (2020). Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12100980"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.molmed.2022.08.003","article-title":"siRNA modification and delivery for drug development","volume":"28","author":"Zhang","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Zogg, H., Singh, R., and Ro, S. (2022). Current Advances in RNA Therapeutics for Human Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052736"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biotechadv.2019.04.012","article-title":"RNAi therapeutic and its innovative biotechnological evolution","volume":"37","author":"Weng","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molmed.2023.10.005","article-title":"Three \u2018E\u2019 challenges for siRNA drug development","volume":"30","author":"Guo","year":"2024","journal-title":"Trends Mol. Med."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.drudis.2008.05.007","article-title":"Chemically modified siRNA: Tools and applications","volume":"13","author":"Watts","year":"2008","journal-title":"Drug Discov. Today"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1261\/rna.25706","article-title":"Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity","volume":"12","author":"Jackson","year":"2006","journal-title":"RNA"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: State of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(97)01507-0","article-title":"Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells","volume":"342","author":"Penso","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/onc.2008.108","article-title":"Methyl jasmonate binds to and detaches mitochondria-bound hexokinase","volume":"27","author":"Goldin","year":"2008","journal-title":"Oncogene"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/10\/1304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:14:00Z","timestamp":1760112840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/10\/1304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":229,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["biom14101304"],"URL":"https:\/\/doi.org\/10.3390\/biom14101304","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]}}}